CN103536535B - 一种达比加群酯脂质体 - Google Patents
一种达比加群酯脂质体 Download PDFInfo
- Publication number
- CN103536535B CN103536535B CN201310537342.2A CN201310537342A CN103536535B CN 103536535 B CN103536535 B CN 103536535B CN 201310537342 A CN201310537342 A CN 201310537342A CN 103536535 B CN103536535 B CN 103536535B
- Authority
- CN
- China
- Prior art keywords
- liposome
- dabigatran etexilate
- dabigatran
- parts
- solid preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310537342.2A CN103536535B (zh) | 2013-10-31 | 2013-10-31 | 一种达比加群酯脂质体 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310537342.2A CN103536535B (zh) | 2013-10-31 | 2013-10-31 | 一种达比加群酯脂质体 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103536535A CN103536535A (zh) | 2014-01-29 |
CN103536535B true CN103536535B (zh) | 2015-04-08 |
Family
ID=49960653
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310537342.2A Active CN103536535B (zh) | 2013-10-31 | 2013-10-31 | 一种达比加群酯脂质体 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103536535B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106913543B (zh) * | 2015-12-28 | 2021-06-04 | 山东新时代药业有限公司 | 一种达比加群酯片剂及其制备方法 |
CN105708798A (zh) * | 2016-03-08 | 2016-06-29 | 中国药科大学 | 一种达比加群酯磷脂复合物纳米乳及其制备方法 |
CN115531318B (zh) * | 2022-10-08 | 2023-04-07 | 山东新时代药业有限公司 | 抗凝血药物达比加群酯脂质体、制备方法及其固体制剂 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101816640A (zh) * | 2010-04-16 | 2010-09-01 | 海南美大制药有限公司 | 普拉格雷脂质体固体制剂 |
CN102633777A (zh) * | 2012-03-31 | 2012-08-15 | 天津药物研究院 | 达比加群酯2-酮戊二酸盐及其制备方法和应用 |
-
2013
- 2013-10-31 CN CN201310537342.2A patent/CN103536535B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101816640A (zh) * | 2010-04-16 | 2010-09-01 | 海南美大制药有限公司 | 普拉格雷脂质体固体制剂 |
CN102633777A (zh) * | 2012-03-31 | 2012-08-15 | 天津药物研究院 | 达比加群酯2-酮戊二酸盐及其制备方法和应用 |
Non-Patent Citations (1)
Title |
---|
达比加群酯甲磺酸盐(dabigatran etexilate mesylate);张孟迪;《中国药物化学杂志》;20110430;第21卷(第2期);165、168页 * |
Also Published As
Publication number | Publication date |
---|---|
CN103536535A (zh) | 2014-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100717661B1 (ko) | 신규 제형 | |
JP2593879B2 (ja) | ジピリダモル又はモピダモルと、0―アセチルサリチル酸とを含む製薬組成物、及びその製造方法 | |
CN101951896B (zh) | 复合制剂 | |
CN102579350B (zh) | 右旋布洛芬脂质体固体制剂 | |
CN103536535B (zh) | 一种达比加群酯脂质体 | |
WO2004087116A2 (es) | Combinación de drogas para la disfunción motora en la enfermedad de parkinson | |
MX2014001746A (es) | Metodo de produccion de niveles fisiologicos y terapeuticos de oxido nitrico por medio de un sistema de suministro oral. | |
KR20140030158A (ko) | 주의력 결핍 장애의 치료를 위한 방법 및 조성물 | |
US10124029B2 (en) | Oral compositions and route of administration for the delivery of a thylakoid extract | |
CN109843269A (zh) | 来那度胺的口服用片剂组合物 | |
US11896598B2 (en) | Appetite suppressant compositions and methods thereof | |
JPH03366B2 (zh) | ||
CN102300561B (zh) | 包含依泽替米贝和辛伐他汀的药物组合物 | |
CN101301318A (zh) | 一种银杏叶提取物口服冻干片及其制备方法 | |
CN109195614A (zh) | 用于治疗和预防神经疾病、神经炎症和阿尔茨海默病的组合物 | |
CN102429879B (zh) | 一种盐酸氨溴索脂质体注射剂 | |
RU2012112051A (ru) | Препараты ингибиторы тромбообразования | |
BR102021000791A2 (pt) | Composição farmacêutica de desintegração oral de nefopam e o processo de preparação da mesma | |
JP5452056B2 (ja) | 経口薬 | |
WO2008063025A1 (en) | Combination drug of cilostazol and ginkgo biloba extracts | |
CN111150713A (zh) | 一种吲达帕胺胶囊及其制备方法 | |
CN103735552A (zh) | 替格瑞洛和西洛他唑的药物组合物及其制备方法和应用 | |
CN102078300A (zh) | 托拉塞米脂质体固体制剂 | |
US8470363B2 (en) | Antihypertensive pharmaceutical composition | |
CN102579345B (zh) | 厄贝沙坦脂质体固体制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 223800 No.5 Yanshan Road, eco Chemical Technology Industrial Park, Suqian City, Jiangsu Province Patentee after: Jiangsu alpha Pharmaceutical Co.,Ltd. Address before: 223800 No.9 Yanshan Road, eco Chemical Technology Industrial Park, Suqian City, Jiangsu Province Patentee before: JIANGSU ALPHA PHARMACEUTICAL Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20221130 Address after: 223800 No. 58 Yangzi Road, Eco-chemical Science and Technology Industrial Park, Suyu District, Suqian City, Jiangsu Province Patentee after: Suqian Shengji Pharmaceutical Technology Co.,Ltd. Address before: 223800 No.5 Yanshan Road, eco Chemical Technology Industrial Park, Suqian City, Jiangsu Province Patentee before: Jiangsu alpha Pharmaceutical Co.,Ltd. |